老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Innate Pharma SA

2.26
+0.17008.13%
盘后：2.16-0.1000-4.42%19:21 EDT
成交量：4.44万
成交额：9.98万
市值：2.12亿
市盈率：-3.51
高：2.30
开：2.24
低：2.20
收：2.09
52周最高：2.71
52周最低：1.17
股本：9,394.83万
流通股本：8,844.50万
量比：0.49
换手率：0.05%
股息：- -
股息率：- -
每股收益(TTM):-0.6440
每股收益(LYR):-0.6458
净资产收益率：-271.37%
总资产收益率：-38.85%
市净率：-8.37
市盈率(LYR):-3.50

数据加载中...

总览公司新闻资讯公告
2026/06/22

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/10

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/09/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/12

SEC问询函

Form CORRESP - Correspondence
2023/04/20

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/06

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/12/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/04

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/07/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/11

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/16

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/01/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/24

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
更多